An exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, on 20 April 2021.

We're expecting renewed growth for Dutch manufacturing in 2025 following a very weak couple of years. Growth remains moderate ...

The national government has concerns about the impact Amsterdam’s plans for an Erotic Center on Zuidasdok near the RAI will ...

The EMA is implementing major changes to accelerate ... in London and reduce its services whilst navigating the move to Amsterdam. By 2019, the agency had begun operating from its new home ...

Panalgo is also opening an office in Amsterdam, the home of the EMA, in order to provide close support for the roll-out and management of the new software at the regulator. Panalgo says IHD’s ...

Full year 2024 total revenues increased by 21% to US$297.2 million and exceeded our guidance, driven by record RUCONEST® revenue and strong Joenja® (leniolisib) growth Fourth quarter 2024 total revenu ...

December 31, 2024 -- NAARDEN, the Netherlands and MIAMI, Feb. 26, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical ...

NewAmsterdam, marked by compelling data from three pivotal Phase 3 trials – BROOKLYN, TANDEM, and BROADWAY ...

uniQure was founded in 1998 as Amsterdam Molecular Therapeutics and ... which was approved by the FDA in November 2022 and by the EMA and Health Canada in 2023. It was officially out-licensed ...

Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025 -- -- Phase 3 PREVAIL CVOT remains on track -- -- ...